Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study

Journal of the American College of Cardiology

Volumn 65, Issue 24, 2015, Pages 2581-2588

  Gold, Michael R ^a   Sommer, Torsten ^b   Schwitter, Juerg ^c   Al Fagih, Ahmed ^d   Albert, Timothy ^e   Merkely, Béla ^f   Peterson, Michael ^g   Ciuffo, Allen ^h   Lee, Sung ⁱ   Landborg, Lynn ^j   Cerkvenik, Jeffrey ^j   Kanal, Emanuel ^k  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b German Red Cross Hospital   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^e Central Coast Cardiology   (United States)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g United Heart and Vascular Clinic   (United States)

^h SENTARA NORFOLK GENERAL HOSPITAL   (United States)

ⁱ WASHINGTON HOSPITAL CENTER   (United States)

^j MEDTRONIC   (United States)

^k UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

implantable cardioverter defibrillator; magnetic resonance imaging

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; R WAVE; RADIOFREQUENCY; ADVERSE EFFECTS; AGED; CARDIOVASCULAR DISEASES; CARDIOVERSION; CLINICAL TRIAL; DEVICES; FOLLOW UP; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOVASCULAR DISEASES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84931034982     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.04.047     Document Type: Article

References (21)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
2. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. ISO/TS10974:2012: Assessment of the Safety of Magnetic Resonance Imaging for Patients With an Active Implantable Medical Device 2012 International Organization for Standardization Geneva, Switzerland
5. E. Kanal, A.J. Barkovich, and C. Bell ACR guidance document on safe MR practices J Magn Reson Imaging 37 2013 501 530
6. C.W. Yancy, M. Jessup, and B. Bozhurt 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
7. J.J.V. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 33 2012 1787 1847
8. S. Nazarian, M.R. Reynolds, and M.P. Ryan Estimating the likelihood of MRI in patients after ICD implantation: a 10-year prediction model (abstr) J Am Coll Cardiol 65 Suppl 10 2015 A1090
9. B.L. Wilkoff, D. Bello, M. Taborsky for the EnRhythm MRI SureScan Pacing System Study Investigators Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment Heart Rhythm 8 2011 65 73
10. R. Gimbel, D. Bello, and M. Schmitt Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla Heart Rhythm 10 2013 685 691
11. W.M. Bailey, L. Rosenthal, and L. Fananapazir Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5T MRI scanning conditions Heart Rhythm 12 2015 1183 1191
12. M.R. Gold, E. Kanal, and J. Schwitter Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use Heart Rhythm 12 2015 631 638
13. J. Shenthar, G. Milasinovic, and A. Al Fagih MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results Heart Rhythm 12 2015 759 765
14. M. Fiek, T. Remp, C. Reithmann, and G. Steinbeck Complete loss of ICD programmability after magnetic resonance imaging Pacing Clin Electrophysiol 27 2004 1002 1004
15. C. Wollmann, M. Grude, and B. Tombach Safe performance of magnetic resonance imaging on a patient with an ICD Pacing Clin Electrophysiol 28 2005 339 342
16. A. Roguin, J.K. Donahue, C.S. Bomma, D.A. Bluemke, and H.R. Halperin Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator Pacing Clin Electrophysiol 28 2005 336 338
17. S. Nazarian, R. Hansford, and A. Roguin A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices Ann Intern Med 155 2011 415 424
18. J.D. Cohen, H.S. Costa, and R.J. Russo 1.5 Tesla for patients with pacemakers and implantable cardiac defibrillators Am J Cardiol 10 2012 1631 1636
19. R.J. Russo for the MagnaSafe Investigators Determining the risks of magnetic resonance imaging at 1.5 Tesla in patients with non-MRI conditional pacemakers and implantable cardioverter defibrillators: final results of the MagnaSafe Registry (abstr) Circulation 130 2014 2118
20. B.L. Wilkoff, T. Albert, and M. Lazebnik Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling Heart Rhythm 10 2013 1815 1821
21. R.G. Hauser, and L. Kallinen Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database Heart Rhythm 4 2004 399 405